PARP1 inhibition protects mice against Japanese encephalitis virus infection.

Japanese encephalitis (JE) is a vector-borne viral disease that causes acute encephalitis in children. Although vaccines have been developed against the JE virus (JEV), no effective antiviral therapy exists. Our study shows that inhibition of poly(ADP-ribose) polymerase 1 (PARP1), an NAD+-dependent (poly-ADP) ribosyl transferase, protects against JEV infection. Interestingly, PARP1 is critical for JEV pathogenesis in Neuro-2a cells and mice. Small molecular inhibitors of PARP1, olaparib, and 3-aminobenzamide (3-AB) significantly reduce clinical signs and viral load in the serum and brains of mice and improve survival. PARP1 inhibition confers protection against JEV infection by inhibiting autophagy. Mechanistically, upon JEV infection, PARP1 PARylates AKT and negatively affects its phosphorylation. In addition, PARP1 transcriptionally upregulates PTEN, the PIP3 phosphatase, negatively regulating AKT. PARP1-mediated AKT inactivation promotes autophagy and JEV pathogenesis by increasing the FoxO activity. Thus, our findings demonstrate PARP1 as a potential mediator of JEV pathogenesis that can be effectively targeted for treating JE.

Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling.

Chronic activation of stress hormones such as glucocorticoids leads to skeletal muscle wasting in mammals. However, the molecular events that mediate glucocorticoid-induced muscle wasting are not well understood. Here, we show that SIRT6, a chromatin-associated deacetylase indirectly regulates glucocorticoid-induced muscle wasting by modulating IGF/PI3K/AKT signaling. Our results show that SIRT6 levels are increased during glucocorticoid-induced reduction of myotube size and during skeletal muscle atrophy in mice. Notably, overexpression of SIRT6 spontaneously decreases the size of primary myotubes in a cell-autonomous manner. On the other hand, SIRT6 depletion increases the diameter of myotubes and protects them against glucocorticoid-induced reduction in myotube size, which is associated with enhanced protein synthesis and repression of atrogenes. In line with this, we find that muscle-specific SIRT6 deficient mice are resistant to glucocorticoid-induced muscle wasting. Mechanistically, we find that SIRT6 deficiency hyperactivates IGF/PI3K/AKT signaling through c-Jun transcription factor-mediated increase in IGF2 expression. The increased activation, in turn, leads to nuclear exclusion and transcriptional repression of the FoxO transcription factor, a key activator of muscle atrophy. Further, we find that pharmacological inhibition of SIRT6 protects against glucocorticoid-induced muscle wasting in mice by regulating IGF/PI3K/AKT signaling implicating the role of SIRT6 in glucocorticoid-induced muscle atrophy.

Electrochemical deposition of mesoporous nickel hydroxide films from dilute surfactant solutions.

A series of micelle-templated mesoporous nickel hydroxide films were prepared by electrochemical deposition from dilute surfactant solutions by using different types of template and by varying plating solvent composition. Lamellar mesostructured Ni(OH)2 films are obtained with only anionic surfactant sodium dodecyl sulfate (SDS) as the template. In particular, a unique cooperative assembly fashion, that is, the combination between Ni2+ and a complex composed of the primary template SDS and a cosurfactant, such as triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) copolymers and poly(ethylene glycol), was explored, by which two-dimensional hexagonal mesoporous Ni(OH)2 films were electrodeposited. Meanwhile, the deposition medium also plays a crucial role in determining the mesostructure of Ni(OH)2 films. For the composite nickel hydroxide films deposited from aqueous solution or dilute aqueous solution of ethylene glycol (<20 wt %) in the presence of SDS or the SDS-poly(alkylene oxide) polymer complexes, a mixed lamellar phase with d(001) = 37.4 A and d(001) = 28.5 A was obtained. However, single lamellar phase with d(001) = 37.4 A was electrodeposited from concentrated aqueous solutions of ethylene glycol (> or = 20 wt %). Furthermore, such deposition baths have access to hexagonal mesoporous nickel hydroxide films with d(100) = 37.4 A at 70 degrees C with the SDS-poly(alkylene oxide) polymer complexes as the templates. Within the potential window for Ni(OH)2, the morphology and quality of mesostructured films are significantly dependent on the deposition potential, while the mesostructures of the composite films always remain unchanged.